Benefit-Risk Factors in Medical Device Product Availability, Compliance, and Enforcement Decisions
This guidance provides a framework for FDA and stakeholders to assess benefit-risk factors when making medical device product availability, compliance, and enforcement decisions. It applies to both diagnostic and therapeutic medical devices subject to and exempt from premarket review, but excludes devices regulated by CBER, combination products where CDRH is not the lead center, and electronic products that are not devices. The guidance aims to improve consistency and transparency in decision-making while focusing on maximizing patient benefit and minimizing risk.
Recommended Actions
- Document benefit assessment considering:
- Type and magnitude of benefits
- Likelihood of patients experiencing benefits
- Duration of effects
- Patient perspective
- Medical necessity
- Document risk assessment considering:
- Severity of harm
- Likelihood of risk
- Distribution of nonconforming devices
- Duration of exposure
- Patient tolerance
- Detectability
- Evaluate additional factors:
- Uncertainty level
- Available mitigations
- Failure modes
- Scope of issues
- Patient impact
- Firm compliance history
- Consider using provided worksheets in appendices for structured benefit-risk assessment
- Implement appropriate mitigation strategies based on benefit-risk assessment outcome
- Monitor effectiveness of decisions and update assessments as new information becomes available
- Maintain documentation of benefit-risk assessments and decision rationale
Key Considerations
Human Factors
- Consider patient perspective on benefits and risks
- Evaluate patient tolerance for risk
- Assess healthcare professional/caregiver benefits and risks
Labelling
- Consider labeling changes as potential mitigation strategy
- Evaluate if benefits and risks are adequately communicated in labeling
Safety
- Assess severity of harm (deaths, serious injuries, non-serious adverse events)
- Evaluate likelihood of risk
- Consider duration of exposure to population
- Analyze failure modes
- Assess detectability of issues
- Consider distribution of nonconforming devices
Other considerations
- Evaluate medical necessity of device
- Consider availability of alternative treatments
- Assess uncertainty in benefit-risk determination
- Review firm compliance history
- Evaluate scope of device issues
- Consider patient impact if device is/isn’t available
- Assess nature of violations/nonconforming product
Relevant Guidances
- Use of ISO 10993-1 for Biological Evaluation and Testing of Medical Devices
- Benefit-Risk Determinations for Medical Device Premarket Review
- Benefit-Risk Assessment with Uncertainty in Medical Device Premarket Submissions
Related references and norms
- ISO 14971: Medical devices – Application of risk management to medical devices
Original guidance
- Benefit-Risk Factors in Medical Device Product Availability, Compliance, and Enforcement Decisions
- HTML / PDF
- Issue date: 2016-12-27
- Last changed date: 2019-03-04
- Status: FINAL
- Official FDA topics: Safety - Issues, Adverse Event Reporting System (FAERS), Laser Notice, Medical Devices, Errors, Postmarket, Adverse Event Reporting, Premarket Approval (PMA), and Problems, 510(k), Combination Products, HUD/HDE, Investigational Device Exemption (IDE), Recalls
- ReguVirta summary file ID: 87dc4fdd62d68b5545e53c45a82947d5
This post is licensed under CC BY 4.0 by the author.